Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paul Harrow"'
Autor:
Saskia Inniss, Konstantinos C. Fragkos, Lisa Whitley, Rachel Wimpory, Eleanor Rebello, Ana Lisboa, Tanvi Khetan, Jasmine Hassan, Kate Simpson, Anisha Bhagwanani, Roser Vega, Ioanna Parisi, Paul Harrow, Edward Seward, Sara McCartney, Stuart Bloom, Andrew M. Smith, Andrew Plumb, Farooq Z. Rahman
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 14 (2023)
Background: Ustekinumab was approved in 2016 for the treatment of moderate–severe Crohn’s disease (CD). Clinical trials and real-world studies have suggested ustekinumab to be a safe and effective treatment; however, studies to date infrequently
Externí odkaz:
https://doaj.org/article/c52af86583284753a2ec0ab03e5eb5ed
Autor:
Fevronia Kiparissi, Sara McCartney, Paul Harrow, Charles Murray, Lisa Whitley, Ioanna Parisi, Chris Wood, Eleanor Rebello
Publikováno v:
BMJ Paediatrics Open, Vol 6, Iss Suppl 1 (2022)
Externí odkaz:
https://doaj.org/article/28a7f3515a984e379493cb1bd7e04afd
Autor:
Charles Miller, Hanson Kwok, Paul Harrow, Roser Vega, Edward Seward, Shameer Mehta, Farooq Rahman, Sara McCartney, Ioanna Parisi, Samuel Hsiang Lim, Esha Sharma, Mark A Samaan, Aaron Bancil, Klaartje Bel Kok, Ahmed Shalabi, Emma L Johnston, Dev Katarey, Nina Taherzadeh, Charles Murray, Mohammed Tauseef Sharip, Martyn J Carter, Shiva T Radhakrishnan, Simon Peake, Imran Khakoo, Mahmood Wahed, Sebastian Povlsen, Mehul Patel, Patrick DuBois, Jemima Finkel, Clive Onnie, Stuart Bloom
Publikováno v:
Frontline Gastroenterol
BackgroundSequential drug treatment with biological agents in ulcerative colitis (UC) is becoming increasingly complex. There are few studies comparing head-to-head outcomes in second-line treatments. The study assesses whether using anti-tumour necr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52be3975bb0779030a7adf9061925c7e
https://doi.org/10.1136/flgastro-2021-101906
https://doi.org/10.1136/flgastro-2021-101906
Autor:
Ioanna Parisi, Chris Wood, Eleanor Rebello, Paul Harrow, Charles Murray, Fevronia Kiparissi, Lisa Whitley, Sara McCartney
Publikováno v:
Poster.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::561184a0a05a7f5bc596a11662c4f450
https://doi.org/10.1136/bmjpo-2022-rcpch.54
https://doi.org/10.1136/bmjpo-2022-rcpch.54
Publikováno v:
Poster presentations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb09867d2092a78fa7019615301163bf
https://doi.org/10.1136/gutjnl-2022-bsg.72
https://doi.org/10.1136/gutjnl-2022-bsg.72
Publikováno v:
Poster presentations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2b2088d752d24dc358be844aefc319
https://doi.org/10.1136/gutjnl-2022-bsg.68
https://doi.org/10.1136/gutjnl-2022-bsg.68
Publikováno v:
Posters.
Introduction Co-presentation with anaemia and acute coronary syndrome (ACS) is common. Anaemia is an independent risk factor for poor outcomes after ACS. Bleeding is the most common non-cardiac complication of ACS therapy. There are few studies exist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf3b55aa52f13ddba5134d347631ca7
https://doi.org/10.1136/gutjnl-2019-bsgabstracts.48
https://doi.org/10.1136/gutjnl-2019-bsgabstracts.48